Showing results (21-30 of 1,103) with videos related to
Sort By:
Pageof 111
Giornale Italiano Di Cardiologia (2006)|July 25, 2012
[Sudden cardiac death in patients with left ventricular dysfunction from ischemic heart disease: role of the implantable defibrillator. Evidence, guidelines and good clinical judgment]Laura Vitali Serdoz, Enrico Fabris, Cristina Lutman, et al.Journal of the American College of Cardiology|March 26, 2011
Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatmentMarco Merlo, Stylianos A Pyxaras, Bruno Pinamonti, et al.The Canadian Journal of Cardiology|December 15, 2022
One-Year Risk of Myocarditis After COVID-19 Infection: A Systematic Review and Meta-analysisMarco Zuin, Gianluca Rigatelli, Claudio Bilato, et al.The American Journal of Cardiology|August 27, 2013
Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditisMichele Moretti, Alessandra Buiatti, Marco Merlo, et al.European Journal of Heart Failure|July 20, 2020
Viral presence-guided immunomodulation in lymphocytic myocarditis: an updateGianfranco Sinagra, Aldostefano Porcari, Piero Gentile, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 6, 2023
Trends in age and sex-specific dilated cardiomyopathy mortality in Italy, 2005-2017Marco Zuin, Gianluca Rigatelli, Aldostefano Porcari, et al.European Heart Journal Supplements : Journal of the European Society of Cardiology|June 12, 2020
Cardiac amyloidosis: do not forget to look for itAldostefano Porcari, Luca Falco, Veronica Lio, et al.Giornale Italiano Di Cardiologia (2006)|June 8, 2022
[Ten questions for the cardiologist about cardiac scintigraphy with bone tracers, amyloidosis and the heart]Aldostefano Porcari, Maddalena Rossi, Franca Dore, et al.Heart Failure Reviews|May 14, 2022
Endomyocardial biopsy in the clinical context: current indications and challenging scenariosAldostefano Porcari, Chiara Baggio, Enrico Fabris, et al.Drugs|August 22, 2019
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying ApproachEnrico Fabris, Marco Merlo, Claudio Rapezzi, et al.Pageof 111